A detailed history of Vanguard Group Inc transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,470,025 shares of ASRT stock, worth $4.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,470,025
Previous 4,470,025 -0.0%
Holding current value
$4.16 Million
Previous $5.54 Million 4.84%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.75 - $1.31 $337,191 - $588,961
-449,589 Reduced 9.14%
4,470,025 $5.54 Million
Q1 2024

May 10, 2024

BUY
$0.79 - $1.14 $32,446 - $46,820
41,071 Added 0.84%
4,919,614 $4.72 Million
Q4 2023

Feb 14, 2024

BUY
$1.02 - $2.57 $353,315 - $890,217
346,388 Added 7.64%
4,878,543 $5.22 Million
Q3 2023

Nov 14, 2023

BUY
$2.52 - $5.69 $4.45 Million - $10.1 Million
1,767,730 Added 63.95%
4,532,155 $11.6 Million
Q2 2023

Aug 14, 2023

BUY
$5.0 - $7.66 $1.76 Million - $2.69 Million
351,209 Added 14.55%
2,764,425 $15 Million
Q1 2023

May 15, 2023

BUY
$3.54 - $6.66 $775,068 - $1.46 Million
218,946 Added 9.98%
2,413,216 $15.4 Million
Q4 2022

Feb 10, 2023

BUY
$2.11 - $4.3 $175,117 - $356,874
82,994 Added 3.93%
2,194,270 $9.44 Million
Q3 2022

Nov 14, 2022

BUY
$2.13 - $4.0 $11,502 - $21,600
5,400 Added 0.26%
2,111,276 $4.79 Million
Q2 2022

Aug 12, 2022

BUY
$1.88 - $3.42 $561,999 - $1.02 Million
298,936 Added 16.54%
2,105,876 $6.21 Million
Q1 2022

May 13, 2022

SELL
$2.06 - $3.0 $228,167 - $332,283
-110,761 Reduced 5.78%
1,806,940 $5.19 Million
Q4 2021

Feb 14, 2022

SELL
$0.86 - $2.3 $2,420 - $6,472
-2,814 Reduced 0.15%
1,917,701 $4.18 Million
Q2 2021

Aug 13, 2021

BUY
$1.48 - $2.88 $2.84 Million - $5.53 Million
1,920,515 New
1,920,515 $3 Million

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $44.8M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.